[1]
|
Bahadoram, S., Davoodi, M., Hassanzadeh, S., et al. (2022) Renal Cell Carcinoma: An Overview of the Epidemiology, Diagnosis, and Treatment. Giornale Italiano di Nefrologia, 3.
|
[2]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[3]
|
陈磊. 1990-2019年中国肾癌发病与死亡趋势分析及其预测研究[D]: [硕士学位论文]. 衡阳: 南华大学, 2022.
https://doi.org/10.27234/d.cnki.gnhuu.2022.000780
|
[4]
|
常冬庆, 王勤章, 丁国富, 等. 肾癌116例临床分析[J]. 中华实用诊断与治疗杂志, 2013, 27(7): 702-703.
|
[5]
|
Patel, H.D., Gupta, M., Joice, G.A., et al. (2019) Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States. European Urology Oncology, 2, 343-348. https://doi.org/10.1016/j.euo.2018.08.023
|
[6]
|
Gonzalez, L.L., Garrie, K. and Turner, M.D. (2020) Role of S100 Proteins in Health and Disease. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1867, Article ID: 118677.
https://doi.org/10.1016/j.bbamcr.2020.118677
|
[7]
|
陈思逸, 来茂德. S100家族蛋白与肾癌关系的研究进展[J]. 中国药科大学学报, 2020, 51(2): 223-230.
|
[8]
|
Chen, H., Xu, C., Jin, Q. and Liu, Z. (2014) S100 Protein Family in Human Cancer. American Journal of Cancer Research, 4, 89-115.
|
[9]
|
Bresnick, A.R., Weber, D.J. and Zimmer, D.B. (2015) S100 Proteins in Cancer. Nature Reviews Cancer, 15, 96-109.
https://doi.org/10.1038/nrc3893
|
[10]
|
王斌, 肖何, 张志敏, 等. 低表达lncRNA LINC00665通过调控S100A13表达抑制膀胱癌侵袭和增殖[J]. 山西医科大学学报, 2020, 51(3): 209-213.
|
[11]
|
谢顺明, 王文晓, 赵文武. miR-149-3p通过靶向S100A4抑制膀胱癌细胞的增殖、迁移和侵袭[J]. 现代肿瘤医学, 2019, 27(1): 12-17.
|
[12]
|
王妍, 田甜, 王灵芝, 等. 钙结合蛋白S100A1对卵巢癌细胞A2780增殖和迁移的影响[J]. 精准医学杂志, 2018, 33(3): 238-241.
|
[13]
|
颜伟, 陈潭琇, 王雅琦, 王灵芝. 沉默S100A10基因对卵巢癌SKOV-3和A2780细胞周期的影响[J]. 实用癌症杂志, 2021, 36(4): 532-535+539.
|
[14]
|
胡文兵, 陶泽璋, 费新雄, 等. 鼻咽癌组织中S100A8和S100A9的表达与预后的相关性[J]. 实用医学杂志, 2019, 35(16): 2587-2591.
|
[15]
|
曹文波, 莫赛军, 柯少瑞, 等. 钙结合蛋白S100A8和S100A9在慢性炎症相关肿瘤发生中的调控作用[J]. 癌变∙畸变∙突变, 2013, 25(5): 403-406.
|
[16]
|
Wang, S., Song, R., Wang, Z., et al. (2018) S100A8/A9 in Inflammation. Frontiers in Immunology, 9, Article 1298.
https://doi.org/10.3389/fimmu.2018.01298
|
[17]
|
田圆, 梁群, 潘郭海容, 吴丽丽. 钙卫蛋白S100A8/A9在脓毒症发生发展中的作用机制[J]. 中国感染控制杂志, 2022, 21(11): 1143-1150.
|
[18]
|
Goyette, J. and Geczy, C.L. (2011) Inflammation-Associated S100 Proteins: New Mechanisms That Regulate Function. Amino Acids, 41, 821-842. https://doi.org/10.1007/s00726-010-0528-0
|
[19]
|
常如琦, 霍丽娟, 田玲琳, 等. S100A8、S100A9在幽门螺杆菌相关胃癌发生发展中的作用研究进展[J]. 中国微生态学杂志, 2018, 30(8): 973-976+980.
|
[20]
|
Vogl, T., Eisenblätter, M., Völler, T., et al. (2014) Alarmin S100A8/S100A9 as a Biomarker for Molecular Imaging of Local In-flammatory Activity. Nature Communications, 5, Article No. 4593. https://doi.org/10.1038/ncomms5593
|
[21]
|
Trinchieri, G. (2012) Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts. Annual Review of Immunology, 30, 677-706. https://doi.org/10.1146/annurev-immunol-020711-075008
|
[22]
|
Balkwill, F. and Mantovani, A. (2001) Inflamma-tion and Cancer: Back to Virchow? Lancet, 357, 539-545.
https://doi.org/10.1016/S0140-6736(00)04046-0
|
[23]
|
Ebbing, J., Mathia, S., Seibert, F.S., et al. (2014) Urinary Calprotectin: A New Diagnostic Marker in Urothelial Carcinoma of the Bladder. World Journal of Urology, 32, 1485-1492. https://doi.org/10.1007/s00345-013-1227-8
|
[24]
|
Zhang, L., Jiang, H., Xu, G., et al. (2015) Proteins S100A8 and S100A9 Are Potential Biomarkers for Renal Cell Carcinoma in the Early Stages: Results from a Proteomic Study Integrated with Bioinformatics Analysis. Molecular Medicine Reports, 11, 4093-4100. https://doi.org/10.3892/mmr.2015.3321
|
[25]
|
Wu, F., Chen, J., Yao, K., et al. (2022) The Infiltration of Neutrophil Granulocytes due to Loss of PTEN Was Associated with Poor Response to Immunotherapy in Renal Cell Carcinoma. Journal of Inflammation Research, 15, 6553- 6567. https://doi.org/10.2147/JIR.S388990
|
[26]
|
An, H.J., Koh, H.M. and Song, D.H. (2019) S100A8 Expression May Have a Prognostic Value in CCRCC Reflecting TNM Staging and Fuhrman Nuclear Grade. Anticancer Research, 39, 4681-4685.
https://doi.org/10.21873/anticanres.13650
|
[27]
|
Koh, H.M., An, H.J., Ko, G.H., et al. (2019) Prognostic Role of S100A9 Expression in Patients with Clear Cell Renal Cell Carcinoma. Medicine, 98, e17188. https://doi.org/10.1097/MD.0000000000017188
|
[28]
|
Zhang, L., Jiang, H., Xu, G., et al. (2016) ITRAQ-Based Quantitative Proteomic Analysis Reveals Potential Early Diagnostic Markers of Clear-Cell Renal Cell Carcinoma. Bio-Science Trends, 10, 210-219.
https://doi.org/10.5582/bst.2016.01055
|
[29]
|
Mirza, Z., Schulten, H.J., Farsi, H.M., et al. (2015) Molecular Interac-tion of a Kinase Inhibitor Midostaurin with Anticancer Drug Targets, S100A8 and EGFR: Transcriptional Profiling and Molecular Docking Study for Kidney Cancer Therapeutics. PLOS ONE, 10, e0119765. https://doi.org/10.1371/journal.pone.0119765
|
[30]
|
Mirza, Z., Schulten, H.J., Farsi, H.M., et al. (2014) Impact of S100A8 Expression on Kidney Cancer Progression and Molecular Docking Studies for Kidney Cancer Therapeutics. An-ticancer Research, 34, 1873-1884.
|
[31]
|
Korndörfer, I.P., Brueckner, F. and Skerra, A. (2007) The Crystal Structure of the Human (S100A8/S100A9)2 Heterotetramer, Calprotectin, Illustrates How Conformational Changes of Interacting α-Helices Can Determine Specific Association of Two EF-hand Proteins. Journal of Molecular Biology, 370, 887-898.
https://doi.org/10.1016/j.jmb.2007.04.065
|